14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.71 $3.40 Thursday, 2nd May 2024 ESPR stock ended at $2.06. This is 0.98% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 4.38% from a day low at $2.03 to a day high of $2.12.
90 days $1.71 $3.40
52 weeks $0.700 $3.40

Historical Esperion Therapeutics prices

Date Open High Low Close Volume
Jul 23, 2020 $45.56 $46.40 $43.77 $44.09 461 080
Jul 22, 2020 $46.75 $46.75 $45.31 $46.03 359 400
Jul 21, 2020 $47.23 $48.00 $46.60 $46.84 295 900
Jul 20, 2020 $48.24 $48.39 $46.41 $46.91 620 400
Jul 17, 2020 $47.39 $49.09 $47.39 $48.20 1 059 700
Jul 16, 2020 $48.46 $48.56 $47.31 $47.45 377 400
Jul 15, 2020 $48.21 $49.50 $47.45 $49.01 467 600
Jul 14, 2020 $47.45 $48.22 $45.63 $47.42 564 400
Jul 13, 2020 $51.19 $52.40 $47.50 $47.58 609 400
Jul 10, 2020 $51.58 $52.40 $51.01 $51.04 232 300
Jul 09, 2020 $52.73 $53.73 $51.14 $51.70 395 500
Jul 08, 2020 $50.87 $52.77 $50.65 $52.71 288 500
Jul 07, 2020 $50.40 $51.60 $49.87 $51.03 395 600
Jul 06, 2020 $50.75 $52.01 $49.78 $50.82 705 400
Jul 02, 2020 $51.84 $52.79 $50.28 $50.96 355 865
Jul 01, 2020 $51.69 $53.59 $50.64 $51.12 668 978
Jun 30, 2020 $47.57 $51.78 $47.11 $51.31 824 171
Jun 29, 2020 $45.99 $48.25 $45.80 $47.64 563 238
Jun 26, 2020 $46.50 $47.13 $45.02 $45.90 764 823
Jun 25, 2020 $45.26 $47.87 $45.20 $46.97 594 576
Jun 24, 2020 $46.68 $48.49 $45.05 $45.54 561 212
Jun 23, 2020 $47.66 $49.95 $46.82 $47.42 942 317
Jun 22, 2020 $44.14 $48.32 $44.00 $46.98 1 087 117
Jun 19, 2020 $44.10 $47.18 $43.53 $43.53 1 624 164
Jun 18, 2020 $44.28 $44.97 $42.99 $43.63 440 814
Click to get the best stock tips daily for free!

About Esperion Therapeutics

Esperion Therapeutics Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration a... ESPR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT